In this study, we demonstrated that the miR-197/CKS1B/STAT3-mediated signaling drives tumor PD-L1 expression, allowing it to function as a biomarker for this cascade in NSCLC. The gene discussed is STAT3; the disease is non-small cell lung carcinoma.